 |
|  | Liver Toxicity Leads FDA to Curb Trovafloxacin Use. : An article from: Family Practice News $5.95 | |
|
|
|
Cardio-pulmonary medical history and the effect on clinical outcome of community-acquired pneumonia infections treated with gemifloxacin
PURPOSE: Gemifloxacin is a potent new fluoroquinolone with excellent activity against community--acquired pneumonia (CAP)pathogens. METHODS: Pooled ...
From CHEST,
10/1/05
by I. Morrissey
| |
|
|
The effect of disease severity on clinical outcome with acute exacerbation of chronic bronchitis patients treated with gemifloxacin
PURPOSE: Gemifloxacin is approved to treat acute bacterial exacerbations of chronic bronchitis (AECB). Patients with AECB associated with COPD and a ...
From CHEST,
10/1/05
by I. Morrissey
| |
|
|
Resistance phenotypes of streptococcus pneumoniae and clinical outcome of respiratory tract infections treated with gemifloxacin
PURPOSE: Gemifloxacin (GEM) is a potent fluoroquinolone with excellent activity against respiratory tract infection (RTI) pathogens, including S. pneumoniae ...
From CHEST,
10/1/05
by Ian Morrissey
| |
|
|
Comparative efficacy of oral and sequential intravenous/oral moxifloxacin in the treatment of community acquired pneumonia in the very elderly
PURPOSE: To evaluate the efficacy and safety of sequential IV/PO and PO moxifloxacin (MXF) versus that of comparator (COMP) antibiotics in very elderly ...
From CHEST,
10/1/05
by Antonio Anzueto
| |
|
|
Adverse drug reactions in the ICU: lessons learned
The development of an adverse drug reaction (ADR) is a common occurrence in the ICU. Estimates for the incidence of ADRs in ICU patients are variable ...
From CHEST,
9/1/05
by Basim A. Dubaybo
| |
|
|
Fluoroquinolones vs macrolides in the treatment of legionnaires disease
Background: Erythromycin has been the treatment of choice for Legionnaires disease (LD). However, treatment failure and experimental evidence of its ...
From CHEST,
9/1/05
by Miquel Sabria
| |
|
|
A New System for Moving Drugs to Market
The pharmaceutical industry is one of the most successful components of the U.S. economy. In recent years, however, critics have increasingly blamed the ...
From Issues in Science and Technology,
1/1/05
by Woosley, Raymond L
| |
|
|
Telithromycin for respiratory tract infections
Synopsis Telithromycin is the first member of the ketolides, a new subclass of the macrolide class of antibiotics. Its activity against common respiratory ...
From American Family Physician,
9/15/04
by M. Sharm Steadman
| |
|
Home
A
Oxytetracycline